Skip to content
OpenCapital
Get started

Kura Oncology KURA ROW License — Contract With Customer Liability Revenue Recognized

Similar metrics at other companies

Travere Therapeutics, Inc. logo
TVTXLicense and collaboration revenue — Contract with Customer, Liability, Revenue Recognized
$718K-50.9%
Ionis Pharmaceuticals logo
IONSContract With Customer Liability Revenue Recognized
$19.6M-52.8%
Diamondrock Hospitality Company logo
DRHContract With Customer Liability Revenue Recognized
$82K-14.6%
Supernus Pharmaceuticals logo
SUPNLicense — Revenue recognized
$20M+433%
Praxis Precision Medicines, Inc. logo
PRAXLicense — Contract with customer, liability, revenue recognized
$0—
Zevra Therapeutics, Inc. logo
ZVRALicense — Contract with customer, liability, revenue recognized, including opening balance
$1.1M—

Other financials

Income statement

See full
Revenue$18.3M+29.5%
Gross profit$18.0M—
Operating income-$78.8M-21.8%
Net income-$73.3M-27.7%
EPS (diluted)-$0.83-25.8%

Balance sheet

See full
Cash & equivalents$39.1M-23.8%
Total debt$24.3M+25.4%
Total equity$107.9M-70.4%
Total assets$652.6M-12.3%

Cash flow

See full
Operating cash flow-$85.9M-19.4%
CapEx$128.0K-56.2%
Free cash flow-$86.0M-19.1%

Valuation

See full
Market cap$919.7M+81.6%
Enterprise value$904.89M+90.7%
P/S12.8×+3.5×

Profitability

See full
Operating margin-443.5%+103pp
Net margin-411.2%+125pp
FCF margin130.6%+74.1pp

Returns & leverage

See full
Return on equity-124.7%-252pp
Debt / equity0.2×+0.2×
Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityRevenueRecognized.

The official record: Kura Oncology’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's row license — contract with customer liability revenue recognized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kura Oncology's ROW license — contract with customer liability revenue recognized?
Kura Oncology (KURA) reported ROW license — contract with customer liability revenue recognized of $5.1M in Q4 2025.
How has Kura Oncology's ROW license — contract with customer liability revenue recognized changed year-over-year?
Kura Oncology's ROW license — contract with customer liability revenue recognized decreased by 59.0% year-over-year, from $12.45M to $5.1M.
What does ROW license — contract with customer liability revenue recognized mean?
This metric represents the amount of revenue recognized during the period that was previously recorded as deferred revenue or a contract liability related to Rest of World (ROW) licensing agreements. It reflects the fulfillment of performance obligations under collaboration or licensing arrangements as the company satisfies its contractual commitments to partners. Tracking this value helps investors understand the pace at which upfront payments or milestone-related liabilities are being converted into recognized revenue over the life of a partnership.